Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

BACKGROUND: Combining different cancer treatments represents a promising strategy to improve the therapeutic outcome for lung cancer patients with or without druggable gene alterations. METHODS: We previously developed a polyethylene glycol-based (PEG-based) immunostimulatory nanocarrier (PEG(2k)-Fm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Diao, Dingwei, Zhai, Jianxue, Yang, Jianjun, Wu, Hua, Jiang, Jianjun, Dong, Xiaoying, Passaro, Antonio, Aramini, Beatrice, Rao, Shuan, Cai, Kaican
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947404/
https://ncbi.nlm.nih.gov/pubmed/33718033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-21-144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados